Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland
TH Open · 01.04.2023 · 07 (02) · e133-e142
DOI: 10.1055/a-2080-6171 ↗Kurz gefasst
Fachartikel in der Zeitschrift TH Open, erschienen am 01.04.2023. Verfasst von Lars Frost und 9 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg, Denmark. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Geographical mapping of variations in the treatment and outcomes of a disease is a valuable tool for identifying inequity. We examined international and intranational variations in initiating oral anticoagulation (OAC) therapy and clinical outcomes among patients with atrial fibrillation (AF) in Nordic countries. We also tracked real-world trends in initiating OAC and the clinical outcomes.
Methods
We conducted a registry-based multinational cohort study of OAC-naive patients with an incident hospital diagnosis of AF in Denmark (N = 61,345), Sweden (N = 124,120), and Finland (N = 59,855) and a CHA2DS2-VASc score of ≥1 in men and ≥2 in women between 2012 and 2017. Initiation of OAC therapy was defined as dispensing at least one prescription between 90 days before and 90 days after the AF diagnosis. Clinical outcomes included ischemic stroke, intracerebral hemorrhage, intracranial bleeding, other major bleeding, and all-cause mortality.
Results
The proportion of patients initiating OAC therapy ranged from 67.7% (95% CI: 67.5–68.0) in Sweden to 69.6% (95% CI: 69.2–70.0) in Finland, with intranational variation. The 1-year risk of stroke varied from 1.9% (95% CI: 1.8–2.0) in Sweden and Finland to 2.3% (95% CI: 2.2–2.4) in Denmark, with intranational variation. The initiation of OAC therapy increased with a preference for direct oral anticoagulants over warfarin. The risk of ischemic stroke decreased with no increase in intracranial and intracerebral bleeding.
Conclusion
We documented inter- and intranational variation in initiating OAC therapy and clinical outcomes across Nordic countries. Adherence to structured care of patients with AF could reduce future variation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Industrial Engineering and Management, Aalto University, Espoo, Finland.
- Department of Internal Medicine, Hospital District of Helsinki and Uusimaa, Lohja Hospital, Lohja, Finland.
- Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Turku University Hospital, University of Turku, Turku, Finland.
ORCID-Profile: Lars Frost, Per Wändell, Søren Paaske Johnsen
Zitieren
APA
Frost, L., Halminen, O., Lehto, M., Airaksinen, K. E. J., Andersson, T., Wändell, P., Holzmann, M., Cordsen, P., Vinter, N., & Johnsen, S. P. (2023). Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland. TH Open, 07(02), e133-e142. https://doi.org/10.1055/a-2080-6171
Vancouver
Frost L, Halminen O, Lehto M, Airaksinen KEJ, Andersson T, Wändell P, et al. Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland. TH Open. 2023;07(02):e133-e142. doi:10.1055/a-2080-6171
BibTeX
@article{Frost2023,
author = {Frost, Lars and Halminen, Olli and Lehto, Mika and Airaksinen, K E Juhani and Andersson, Tomas and Wändell, Per and Holzmann, Martin and Cordsen, Pia and Vinter, Nicklas and Johnsen, Søren Paaske},
title = {Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland},
journal = {TH Open},
year = {2023},
volume = {07},
number = {02},
pages = {e133--e142},
doi = {10.1055/a-2080-6171}
}
EUVIMED